{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:39:29Z","timestamp":1776911969736,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"DOI":"10.1007\/s00381-026-07275-z","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:04:02Z","timestamp":1776909842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiological complete response in diffuse intrinsic pontine glioma: a case report"],"prefix":"10.1007","volume":"42","author":[{"given":"Rejin","family":"Kebudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4811-5750","authenticated-orcid":false,"given":"Yasin","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulku Miray","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebuh","family":"Kurugoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serra","family":"Sencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulya","family":"Agaoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"7275_CR1","unstructured":"Varlet P, Ellison DW, Solomon DA, Suva ML, Baker SJ, Jabado N et al. (2021) Diffuse midline glioma, H3 K27\u2013altered. In: WHO Classification of Tumours Editorial Board. Central nervous system tumours [Internet]. Lyon (France): International Agency for Research on Cancer;\u00a0 [cited March 2025]. (WHO classification of tumours series, 5th ed.; vol. 6). Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/45"},{"issue":"6","key":"7275_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3171\/2023.7.PEDS22462","volume":"32","author":"M Dalmage","year":"2023","unstructured":"Dalmage M, LoPresti MA, Sarkar P, Ranganathan S, Abdelmageed S, Pagadala M et al (2023) Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review. J Neurosurg Pediatr 32(6):665\u2013672. https:\/\/doi.org\/10.3171\/2023.7.PEDS22462","journal-title":"J Neurosurg Pediatr"},{"key":"7275_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcped.2024.100210","volume":"5","author":"E Szychot","year":"2025","unstructured":"Szychot E, Giraud G, Hargrave D, van Vuurden D, Grill J, Biassoni V et al (2025) European standard clinical practice recommendations for paediatric high-grade gliomas. Eur J Cancer 5. https:\/\/doi.org\/10.1016\/j.ejcped.2024.100210","journal-title":"Eur J Cancer"},{"issue":"3","key":"7275_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7030069","volume":"2019","author":"H Strobel","year":"2019","unstructured":"Strobel H, Baisch T, Fitzel R, Schilberg K, Siegelin MD, Karpel-Massler G et al (2019) Temozolomide and other alkylating agents in glioblastoma therapy. Biomedicines 2019(3). https:\/\/doi.org\/10.3390\/biomedicines7030069","journal-title":"Biomedicines"},{"issue":"4","key":"7275_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00381-012-1986-3","volume":"29","author":"R Kebudi","year":"2013","unstructured":"Kebudi R, Cakir FB, Agaoglu FY, Gorgun O, Ayan I, Darendeliler E (2013) Pediatric diffuse intrinsic pontine glioma patients from a single center. Childs Nerv Syst 29(4):583\u2013588. https:\/\/doi.org\/10.1007\/s00381-012-1986-3","journal-title":"Childs Nerv Syst"},{"issue":"18","key":"7275_CR6","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1016\/j.ejca.2013.08.006","volume":"49","author":"S Bailey","year":"2013","unstructured":"Bailey S, Howman A, Wheatley K, Wherton D, Boota N, Pizer B et al (2013) Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy - results of a United Kingdom phase II trial (CNS 2007 04). Eur J Cancer 49(18):3856\u20133862. https:\/\/doi.org\/10.1016\/j.ejca.2013.08.006","journal-title":"Eur J Cancer"},{"issue":"4","key":"7275_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/neuonc\/noq205","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E et al (2011) Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children\u2019s Oncology Group. Neuro-oncol 13(4):410\u2013416. https:\/\/doi.org\/10.1093\/neuonc\/noq205","journal-title":"Neuro-oncol"},{"issue":"9","key":"7275_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12092064","volume":"12","author":"V Di Ruscio","year":"2022","unstructured":"Di Ruscio V, Del Baldo G, Fabozzi F, Vinci M, Cacchione A, de Billy E et al (2022) Pediatric diffuse midline gliomas: an unfinished puzzle. Diagnostics 12(9). https:\/\/doi.org\/10.3390\/diagnostics12092064","journal-title":"Diagnostics"},{"issue":"42","key":"7275_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022721","volume":"99","author":"J Park","year":"2020","unstructured":"Park J, Yea JW, Park JW (2020) Hypofractionated radiotherapy versus conventional radiotherapy for diffuse intrinsic pontine glioma: a systematic review and meta-analysis. Medicine (Baltimore) 99(42). https:\/\/doi.org\/10.1097\/MD.0000000000022721","journal-title":"Medicine (Baltimore)"},{"key":"7275_CR10","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.944869","volume":"25","author":"AD Uke","year":"2024","unstructured":"Uke AD, Luharia A, Dahake S, Mishra GV, Mahakalkar C (2024) Exceptional tumor regression in diffuse intrinsic pontine glioma post-radiotherapy: a case study. Am J Case Rep 25. https:\/\/doi.org\/10.12659\/AJCR.944869","journal-title":"Am J Case Rep"},{"issue":"2","key":"7275_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11060-022-04079-4","volume":"159","author":"M Massimino","year":"2022","unstructured":"Massimino M, Vennarini S, Barretta F, Colombo F, Antonelli M, Pollo B et al (2022) How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatment. J Neurooncol 159(2):437\u2013445. https:\/\/doi.org\/10.1007\/s11060-022-04079-4","journal-title":"J Neurooncol"},{"key":"7275_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2016.12.007.","volume":"73","author":"GO Janssens","year":"2017","unstructured":"Janssens GO, Gandola L, Bolle S, Mandeville H, Ramos-Albiac M, van Beek K et al (2017) Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG\/DIPG working group. Eur J Cancer 73:38\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2016.12.007.","journal-title":"Eur J Cancer"},{"issue":"1","key":"7275_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/nop\/npaa063","volume":"8","author":"C Cacciotti","year":"2020","unstructured":"Cacciotti C, Liu KX, Haas-Kogan DA, Warren KE (2020) Reirradiation practices for children with diffuse intrinsic pontine glioma. Neuro-oncol Pract 8(1):68\u201374. https:\/\/doi.org\/10.1093\/nop\/npaa063","journal-title":"Neuro-oncol Pract"},{"issue":"Suppl 1","key":"7275_CR14","doi-asserted-by":"publisher","first-page":"i63","DOI":"10.1093\/neuonc\/noac079.231","volume":"24","author":"AO von Bueren","year":"2022","unstructured":"von Bueren AO, Kwiecien R, Gielen GH, Benesch M, Perwein T, Nussbaumer G, Sturm D, Jones DTW, Pfister SM, Eyrich M, Rutkowski S, Fleischhack G, von Buiren M, Karremann M, Kortmann RD, Hagel C, Calaminus G, Faldum A, Bison B, Pietsch T, Hoffmann M, Kramm CM (2022) HGG-16. Final analysis of the HIT-HGG-2007 trial (ISRCTN19852453): significant survival benefit for pontine and non-pontine pediatric high-grade gliomas in comparison to previous HIT-GBM-C\/-D trials. Neuro Oncol 24(Suppl 1):i63. https:\/\/doi.org\/10.1093\/neuonc\/noac079.231","journal-title":"Neuro Oncol"},{"key":"7275_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/10732748211053927","volume":"29","author":"MA Parenrengi","year":"2022","unstructured":"Parenrengi MA, Suryaningtyas W, Al Fauzi A, Hafid Bajamal A, Kusumastuti K, Utomo B et al (2022) Nimotuzumab as additional therapy for GLIOMA in pediatric and adolescent: a systematic review. Cancer Control 29. https:\/\/doi.org\/10.1177\/10732748211053927","journal-title":"Cancer Control"},{"issue":"2","key":"7275_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11060-014-1428-z","volume":"118","author":"M Massimino","year":"2014","unstructured":"Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M, Modena P et al (2014) Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood. J Neurooncol 118(2):305\u2013312. https:\/\/doi.org\/10.1007\/s11060-014-1428-z","journal-title":"J Neurooncol"},{"issue":"2","key":"7275_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1517\/14712598.2011.546341","volume":"11","author":"M Massimino","year":"2011","unstructured":"Massimino M, Bode U, Biassoni V, Fleischhack G (2011) Nimotuzumab for pediatric diffuse intrinsic pontine gliomas. Expert Opin Biol Ther 11(2):247\u2013256. https:\/\/doi.org\/10.1517\/14712598.2011.546341","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"7275_CR18","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00381-024-06329-4","volume":"40","author":"A \u00d6zkan","year":"2024","unstructured":"\u00d6zkan A, Ya\u011fc\u0131 K\u00fcpeli B, K\u00fcpeli S, Sezgin G, Bayram \u0130 (2024) Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma. Childs Nerv Syst 40(6):1671\u20131680. https:\/\/doi.org\/10.1007\/s00381-024-06329-4","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"7275_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11060-019-03140-z","volume":"143","author":"G Fleischhack","year":"2019","unstructured":"Fleischhack G, Massimino M, Warmuth-Metz M, Khuhlaeva E, Janssen G, Graf N et al (2019) Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study. J Neurooncol 143(1):107\u2013113. https:\/\/doi.org\/10.1007\/s11060-019-03140-z","journal-title":"J Neurooncol"},{"issue":"1","key":"7275_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00381-018-4001-9","volume":"35","author":"R Kebudi","year":"2019","unstructured":"Kebudi R, Cakir FB, Bay SB, Gorgun O, Alt\u0131nok P, Iribas A et al (2019) Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature. Childs Nerv Syst 35(1):83\u201389. https:\/\/doi.org\/10.1007\/s00381-018-4001-9","journal-title":"Childs Nerv Syst"},{"issue":"19","key":"7275_CR21","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","volume":"36","author":"LM Hoffman","year":"2018","unstructured":"Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M et al (2018) Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International and European Society for Pediatric Oncology DIPG registries. J Clin Oncol 36(19):1963\u20131972. https:\/\/doi.org\/10.1200\/JCO.2017.75.9308","journal-title":"J Clin Oncol"},{"issue":"1","key":"7275_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/neuonc\/noab140","volume":"24","author":"C Erker","year":"2022","unstructured":"Erker C, Lane A, Chaney B, Leary S, Minturn JE, Bartels U et al (2022) Characteristics of patients \u226510 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG\/DMG Registry. Neuro Oncol 24(1):141\u2013152. https:\/\/doi.org\/10.1093\/neuonc\/noab140","journal-title":"Neuro Oncol"},{"issue":"4","key":"7275_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/mph.0000000000002853","volume":"46","author":"E Dimentberg","year":"2024","unstructured":"Dimentberg E, Marceau MP, Lachance A, Bergeron-Gravel S, Saikali S, Crevier L, Bourget C, Hawkins C, Jabado N, Giannakouros P, Renzi S, Larouche V (2024) Very long-term survivorship in pediatric DIPG: case report and review of the literature. J Pediatr Hematol Oncol 46(4):211\u2013215. https:\/\/doi.org\/10.1097\/mph.0000000000002853","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"7275_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11060-013-1189-0","volume":"114","author":"S Jackson","year":"2013","unstructured":"Jackson S, Patay Z, Howarth R, Pai Panandiker AS, Onar-Thomas A, Gajjar A, Broniscer A (2013) Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma. J Neurooncol 114(3):339\u2013344. https:\/\/doi.org\/10.1007\/s11060-013-1189-0","journal-title":"J Neurooncol"},{"issue":"06","key":"7275_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1055\/a-1849-1478","volume":"234","author":"A Stock","year":"2022","unstructured":"Stock A, Brackmann H, Warmuth-Metz M, Miller E, Eyrich M, Kramm CM, Schlegel PG, Wiegering VA (2022) DIPG- Very Long-Term Survivors \u2013 are There Factors Which May Predict a Better Outcome? [DIPG (Ponsgliome)-Langzeit\u00fcberleber \u2013 gibt es Faktoren, die mit einem besseren \u00dcberleben assoziiert sind?]. Klin Padiatr 234(06):391\u2013394. https:\/\/doi.org\/10.1055\/a-1849-1478","journal-title":"Klin Padiatr"},{"issue":"1","key":"7275_CR26","doi-asserted-by":"publisher","DOI":"10.23937\/2469-5866\/1410038","volume":"7","author":"SR Burzynski","year":"2021","unstructured":"Burzynski SR, Burzynski GS, Janicki TJ, Beenken S (2021) Long-term survival (23 years) in a 26-year-old male after antineoplaston therapy for a progressive, diffuse intrinsic pontine glioma: a case report. International Journal of Brain Disorders and Treatment 7(1). https:\/\/doi.org\/10.23937\/2469-5866\/1410038","journal-title":"International Journal of Brain Disorders and Treatment"},{"issue":"12","key":"7275_CR27","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s00381-014-2511-7","volume":"30","author":"M Massimino","year":"2014","unstructured":"Massimino M, Clerici CA (2014) Commentary: the response and survival of children with recurrent diffuse intrisic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, by Burzynski G, et al. Childs Nerv Syst 30(12):2065\u20132066. https:\/\/doi.org\/10.1007\/s00381-014-2511-7","journal-title":"Childs Nerv Syst"},{"key":"7275_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26751","author":"M Porkholm","year":"2018","unstructured":"Porkholm M, Raunio A, Vainionp\u00e4\u00e4 R, Salonen T, Hernesniemi J, Valanne L et al (2018) Molecular alterations in pediatric brainstem gliomas. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.26751","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"7275_CR29","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/neuonc\/noac123","volume":"24","author":"AL Bartlett","year":"2022","unstructured":"Bartlett AL, Lane A, Chaney B, Escorza NY, Black K, Cochrane A et al (2022) Characteristics of children \u226436 months of age with DIPG: A report from the international DIPG registry. Neuro Oncol 24(12):2190\u20132199. https:\/\/doi.org\/10.1093\/neuonc\/noac123","journal-title":"Neuro Oncol"},{"issue":"2","key":"7275_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.21037\/tcr.2019.03.12","volume":"8","author":"F Carceller","year":"2019","unstructured":"Carceller F (2019) Long-term survivors of diffuse intrinsic pontine glioma (DIPG): myth or reality. Transl Cancer Res 8(2):343\u2013345. https:\/\/doi.org\/10.21037\/tcr.2019.03.12","journal-title":"Transl Cancer Res"},{"issue":"12","key":"7275_CR31","doi-asserted-by":"publisher","first-page":"7962","DOI":"10.1007\/s00330-024-10855-9","volume":"34","author":"X Yu","year":"2024","unstructured":"Yu X, Li S, Mai W, Hua X, Sun M, Lai M et al (2024) Pediatric diffuse intrinsic pontine glioma radiotherapy response prediction: MRI morphology and T2 intensity-based quantitative analyses. Eur Radiol 34(12):7962\u20137972. https:\/\/doi.org\/10.1007\/s00330-024-10855-9","journal-title":"Eur Radiol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07275-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-026-07275-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07275-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:04:05Z","timestamp":1776909845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-026-07275-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7275"],"URL":"https:\/\/doi.org\/10.1007\/s00381-026-07275-z","relation":{},"ISSN":["1433-0350"],"issn-type":[{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}